Buy PRA Health Sciences (NSDQ:PRAH) Target: $94 Buy Up To: $74 For subscribers who prefer an option trade: Buy to open the July 21, 2017 call on PRA Health Sciences (PRAH) with a strike price of $75 at $2.25 or lower. Symbol (PRAH170721C75) I’ve been waiting and hoping… Read More
Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities. She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.
She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.
Analyst Articles
Pundits will have you believing that retail employees are becoming extinct- nothing is farther from the truth. Read More
Profit Catalyst Alert had ELEVEN companies report earnings. I’ve covered all of them here in this week’s update and didn't want to short-change any of the names as many reported great quarters with robust outlooks. Read More
Sell to close the July 21, 2017 put on Spectrum Brands (SPB) with a strike price of $130 at $4.55 or higher. Symbol (SPB170721P130) for a 42% gain in less than one month. These options have not traded today but the stock is falling fast so sell at… Read More
Sell to close the July 21, 2017 put on Spectrum Brands (SPB) with a strike price of $130 at $4.55 or higher (Symbol: SPB170721P130) for a 42% gain in less than one month. These options have not traded today but the stock is falling fast so… Read More
Fasten your seatbelt it’s going to be a busy week. We are right in the heart of earnings season. While all of our positions are dependent on good results, many of our option positions are timed on news coming out of this first quarter cycle. Read More
Mueller is down 8% after earnings and a conference call this morning. I believe the weakness is due to weak guidance for its traditional water products. Despite a hiccup in its basic products, the company is booking big gains in its technology division. Revenue from Mueller Co- the company’s division… Read More
When I recommended building supplier Gypsum Supply & Management (NYSE: GMS) last September, the stock was trading at just 10 times 2017 estimates. It has since roared up 66% without a big bump to estimates. I still like the stock but think its current price reflects potential earnings. Read More
Preventative and self-care products are growing at three times the growth rate of traditional over the counter sick-remedy items. CVS is poised to thrive on the trend. Read More
Earnings season for the Profit Catalyst Portfolio officially kicks off this week with earnings from recent portfolio addition Mueller Water (NYSE: MWA) this Thursday. I issued a sell alert this morning on the MWA May $12.50 calls. The stock was trading above… Read More